Kaposiform Hemangioendothelioma
📧 Sign up to get email alerts when something new happens for Kaposiform Hemangioendothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies [Phase 2]
Phase 2 trial evaluating sirolimus for safety and efficacy in complicated vascular anomalies has completed. Results were posted on 2026-01-0…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma [Phase 2]
This clinical trial update discusses Phase 2 research on sirolimus discontinuation strategies in Kaposiform Hemangioendothelioma. The study …
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma
A clinical trial evaluating the effect of sirolimus on immunizations in patients with Kaposiform Hemangioendothelioma is currently recruitin…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Identification of Biomarkers for Patients with Vascular Anomalies
Update on a clinical trial investigating biomarkers in patients with vascular anomalies; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma. [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of different sirolimus concentrations for Kaposiform Hemangioendothelioma has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma [Phase 2]
Phase 2 clinical trial evaluating tacrolimus for superficial Kaposiform Hemangioendothelioma and Tufted Angioma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies [Phase 4]
Phase 4 clinical trial update evaluating percutaneous sirolimus for superficial complicated vascular anomalies, including Kaposiform Hemangi…
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma [Phase 2]
Phase 2 trial evaluating different doses of sirolimus for maintenance treatment of Kaposiform Hemangioendothelioma.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma [Phase 4]
A Phase 4 trial comparing guided discontinuation versus maintenance sirolimus in pediatric Kaposiform Hemangioendothelioma and Kasabach-Merr…
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma [Phase 4]
Phase 4 trial update evaluating low-dose sirolimus for Kaposiform Hemangioendothelioma and related hemangiomas completed.
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma [Phase 2]
Phase 2 trial comparing sirolimus alone versus sirolimus with prednisolone for Kaposiform Hemangioendothelioma, completed.
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors [Phase 2]
Phase 2 clinical trial comparing vincristine to sirolimus for high-risk vascular tumors including Kaposiform Hemangioendothelioma and Kasaba…